Therefore, it seems plausible that selective inhibition of AC5 would have therapeutic effects on HF and arrhythmia, like β-blockers, but without causing adverse effects on cardiac function and the respiratory tract. This evidence concerns the gene ADCY5 and hydrops fetalis.